Commemorative Series No. 2 · The Drug Money
OUTSPENTNo. 08/54
Ron
Wyden
U.S. Senate · D-OR
Taken from pharma & insurers
$164,825
H.R.1 · Medicare drug-price ban · 2003tap to flip ⤺
WHO THEY WORK FORNo. 08/54
Pharma & Health$102,275
Insurers & HMOs$62,550
Banned Medicare from negotiating drug prices for 19 years. Once it could (2024), prices fell 38–79%. · 108-1-459OUTSPENT
Card 8 of 54 · tap the card to see who they work for
Beyond the check
The check is only the part you can see.
They took
$164,825
The industry spent on the bill
$116M
on drug-industry lobbying in 2003, about ten lobbyists for every senator
Through the leadership PAC
Beyond the campaign account, a leadership PAC under Wyden's control (Hoops PAC) took $410,750 from banks, card lenders, drug makers and insurers.
Source: FEC; Hoops PAC
The industry figure is lobbying spent on the bill, not a payment to this senator. Source: Public Citizen (2004); Center for Public Integrity. Everything here is documented public record; nothing alleges an illegal act.
Don't recognize a logo? Here's the key.
Pharma & Health$102,275
Johnson & Johnson$65,725
PhRMA$12,500
Amgen$9,400
Eli Lilly$7,600
Merck$5,800
Pfizer$1,000
Bristol Myers Squibb$250
Insurers & HMOs$62,550
Centene$34,500
AHIP$22,500
Aetna$5,050
Anthem/Elevance$500